Chemistry: analytical and immunological testing – Lipids – triglycerides – cholesterol – or lipoproteins
Reexamination Certificate
2006-03-21
2006-03-21
Gakh, Yelena G. (Department: 1743)
Chemistry: analytical and immunological testing
Lipids, triglycerides, cholesterol, or lipoproteins
C436S173000, C436S811000
Reexamination Certificate
active
07015044
ABSTRACT:
A method for diagnosing Alzheimer's disease even at early stages by assessing the levels of sulfatides or its metabolites in biological fluids is disclosed.
REFERENCES:
patent: 2001/0044126 (2001-11-01), Holtzman et al.
patent: WO 01/49875 (2001-07-01), None
Bosio, A., et al., “Functional Breakdown of the Lipid Bilayer of the Myelin Membrane in Central and Perioheral Nervous System by Disrupted Galactocerebroside Synthesis” Proc. Natl. Acad. Sci. USA (1996) 93:13280-13285.
Coetzee, T., et al., “Myelination in the Absence of Galactocerebroside and Sulfatide: Normal Structure with Abnormal Function and Regional Instability” Cell (1996) 86:209-219.
Fredman, P., et al., “Sulfatide as a Biochemical Marker in Cerebrospinal Fluid of Patients with Vascular Dementia” Acta Neurol. Scand. (1992) 85:103-106.
Galasko, D., et al., “High Cerebrospinal Fluid Tau and Low Amyloid β42 Levels in the Clinical Diagnosis of Alzheimer Disease and Relation to Apolipoprotein E Genotype” Arc. Neurol. (1998) 55:937-945.
Gottfries, C-G., et al., “Membrane Components Separate Early-Onset Alzheimer's Disease from Senile Dementia of the Alzheimer Type” Int. Psycho-Geriatrics (1996) 8:365-372.
Han, X. et al., “Substantial Sulfatide Deficiency and Ceramide Elevation in Very Early Alzheimer's Disease: Potential Role in Disease Pathogenesis” J. Neurochem. (2002) 82:809-818.
Hannun, Y.A. et al., “Functions of Ceramide in Coordinating Cellular Reponses to Stress” Science (1996) 274:1855-1859.
Hess, B., et al., Proc. “Phenotype of Arylsulfatase A-Deficient Mice: Relationship to Human Metachromatic Leukodystrophy” Natl. Acad. Sci. USA (1996) 93:14821-14826.
Kolesnick, R.N., et al., “Regulation of Ceramide Production and Apoptosis” Ann. Rev. Physiol. (1998) 60:643-665.
Morris, J.C., “The Clinical Dementia Rating (CDR): Current Version and Scoring Rules” Neurology (1993) 43:2412-2414.
Paola, M.D., et al., “Ceramide Interaction with the Respiratory Chain of Heart Mitochondria” Biochemistry (2000) 39:6660-6668.
Svennerholm, L., “Krabbe Disease: A Galactosylsphingosine (Psychosine) Lipidosis” J. Lipid Res. (1980) 21:53-64.
International Preliminary Examination Report, mailed on Oct. 29, 2003, for PCT patent application No. PCT/US02/39567, filed on Dec. 10, 2002, 5 pages.
Majocha et al., J. Neurochem. (1989) 53(3):953-961 (abstract).
Sorbi et al., Gerontology (1987) 33:197-202.
Supplementary European Search Report for EP 02 80 4772, mailed on Dec. 10, 2004, 1. page.
Tarvonen-Schröder et al., Dement. Geriatr. Cogn. Disord. (1997) 8:174-179.
Gottfries et al. (1986)Prog Neuropsychopharmacol Biol Psychiatry10(3-5):405-413 (Abstract).
Han Xianlin
Holtzman David M.
Gakh Yelena G.
Morrison & Foerster / LLP
Washington University
LandOfFree
Diagnostic for early stage Alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnostic for early stage Alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnostic for early stage Alzheimer's disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3542651